Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma

Perioperative mortality and overall survival are significantly associated with the time interval between neoadjuvant chemoradiation and esophagectomy. A “wait and see” approach after neoadjuvant therapy for esophageal adenocarcinoma may not be safe. Further studies based on more detailed data are needed.